CureGenetics
Suzhou
About CureGenetics
Cure Genetics is a biotechnology company developing cutting-edge applications of technologies in innovative medicines and molecular diagnostics for the next-generation treatment of cancers and genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $95.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2024)
- Website: curegenetics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/curegenetics-68016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.